Sana Biotechnology (SANA) Shares Outstanding (Weighted Average) (2020 - 2026)

Sana Biotechnology's Shares Outstanding (Weighted Average) history runs 7 years deep, the most recent figure standing at $276.9 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 16.53% year-over-year to $276.9 million; the TTM figure through Mar 2026 stood at $276.9 million (up 16.53% YoY), while the FY2025 annual figure was $253.2 million, up 9.68% from the prior year.
• Shares Outstanding (Weighted Average) came in at $276.9 million for Q1 2026 at Sana Biotechnology, up from $253.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $276.9 million in Q1 2026 to a low of $186.0 million in Q1 2022.
• A 5-year average of $216.4 million and a median of $217.3 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) soared 56.09% in 2022 and advanced 2.72% in 2023, its largest moves.
• Sana Biotechnology's Shares Outstanding (Weighted Average) stood at $188.3 million in 2022, then advanced by 3.29% to $194.5 million in 2023, then gained by 18.69% to $230.9 million in 2024, then increased by 9.68% to $253.2 million in 2025, then increased by 9.33% to $276.9 million in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $276.9 million, $253.2 million, and $245.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison